Profound Medical Corp PROF 深 滬
已收盤 05-08 16:00:00 美东时间
6.85
-0.310
-4.33%
華盛通- 最 高7.8899
- 今 開7.29
- 成交量 18.94万股
- 最 低 6.81
- 昨 收 7.16
- 總市值 24.86万
- 52周最高 8.95
- 市盈率 靜 --
- 換手率 0.52%
- 52周最低 3.76
- 委 比 79.69%
- 總股本 3.63万
- 歷史最高 28.97
- 量 比 2.17
- 振 幅 15.08%
- 歷史最低 3.10
- 每 手 1
- 風險率 1.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Profound Medical Sees FY2026 Sales $25.000M
Profound Medical (CSE2: PRN) sees FY2026 sales of $25.000 million.
05-08 04:51
Why Medtech Giants Are Quietly Paying Up for AI Diagnostics
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER, BC, April 29, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – There's a quiet bidding war underway for AI diagnostics, and...
04-29 22:30
Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone
Toronto, March 27 - Profound Medical announced that Texas Prostate, led by Dr. James Cochran, has completed its 100th TULSA Procedure at Dallas Medical Center. The TULSA Procedure, utilizing real-time MRI guidance and thermography, offers enhanced precision and safety for treating prostate diseases. Since collaborating with Dallas Medical Center, Dr. Cochran saw a 500% increase in procedures, highlighting the procedure's versatility across prosta...
03-27 11:45
Top 3 Health Care Stocks That Are Set To Fly In March
Opportunity to buy undervalued health care stocks. RSI is a momentum indicator that compares strength on up and down days. Here's a list of oversold stocks with RSI near or below 30.
03-20 18:23
CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence
Profound Medical Corp. announced the superior safety outcomes of the TULSA Procedure compared to robotic radical prostatectomy (RP) in men with localized prostate cancer in the CAPTAIN trial, exceeding enrollment targets with 211 patients. At 6 months, 50% of TULSA patients preserved erectile function and continence vs. 24% with RP (p<0.05). Urinary continence rates were 84% for TULSA vs. 49% for RP, and erectile function was preserved in 56% of ...
03-13 14:30
Profound Medical Earnings Call Maps Path to Profit
Profound Medical (($TSE:PRN)) has held its Q4 earnings call. Read on for the ma...
03-08 08:30
Profound Medical Q4 EPS $(0.27) Beats $(0.38) Estimate, Sales $5.977M Miss $10.532M Estimate.
Profound Medical (TSX:PRN) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.38) by 28.95 percent. This is a 35 percent decrease over losses of $(0.20) per share from the
03-06 05:28
Profound Medical shares are trading lower after the company reported worse-than-expected Q4 financial results.
Profound Medical shares are trading lower after the company reported worse-than...
03-06 05:24
Earnings Summary: Profound Medical Q4
The Q4 earnings report for Profound Medical (NASDAQ:PROF) was released on Thurs...
03-06 05:08
Earnings Scheduled For March 5, 2026
Companies Reporting Before The Bell • Palladyne AI (NASDAQ:PDYN) is projected t...
03-05 19:11
